NSETrading Window24 Jun 2026 · 24 Jun 2026, 04:23 pm

Trading Window

Medicamen Biotech Limited · MEDICAMEQ

✦ AI Summary

Medicamen Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed for all Directors/Designated Persons/Connected Persons from July 01, 2026, and will remain closed till 48 hours after the declaration of Un-audited Financial Results for the quarter ended on June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Medicamen Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

MEDICAMEQ_24062026162325_Trading_window_closure-Intimation.pdf

pdf

Download →
View document text
Date: 24.06.2026 BSE Limited National Stock Exchange of India Limited 25th Floor Exchange Plaza, C-1, Phiroze Jeejebhoy Towers Block - G Bandra Kurla Dalal Street, Mumbai 400 001 Complex Bandra (East) Mumbai – 400 051 BSE Code-531146 NSE Code: MEDICAMEQ Sub. : Intimation of Closure of Trading Window Dear Sir, In terms of the provisions of the Code of Conduct to Regulate, Monitor and Report trading by Designated Persons and their immediate relative (“the Code”), the "Trading Window" for dealing in the securities of the Company will be closed for all Directors / Designated Persons /Connected Persons under the Code from July 01, 2026 and the same will remain closed till 48 hours after the declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended on June 30, 2026, to the public. Accordingly, all Directors / Designated Persons / Connected Persons under the Code have been advised not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. The date of meeting of the Board of Directors of the Company inter alia, to approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the aforesaid period will be intimated separately in due course of time. We request you to take the same on record. Thanking You. Yours Faithfully For Medicamen Biotech Limited Parul Choudhary Company Secretary ACS-44157